Relaciones entre el factor-1α inducido por hipoxia y los parámetros de la PET/TC con 18F-FDG en el cáncer colorrectal-Reference-Cited by-同舟云学术

Relaciones entre el factor-1α inducido por hipoxia y los parámetros de la PET/TC con 18F-FDG en el cáncer colorrectal

Published:2019-11 Issue:6 Volume:38 Page:355-361
ISSN:2253-654X
Container-title:Revista Española de Medicina Nuclear e Imagen Molecular
language:es
Short-container-title:Revista Española de Medicina Nuclear e Imagen Molecular

Author:

Hasbek Z.,Ozer H.,Erturk S.A.,Erdiş E.,Yucel B.,Çiftçi E.,Çakmakcilar A.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging

Reference22 articles.

1. Colorectal cancer;Brenner;Lancet.,2014

2. The preoperative SUVmax for (18)F-FDG uptake predicts survival in patients with colorectal cancer;Shi;BMC Cancer.,2015

3. Current molecular imaging positron emitting radiotracers in oncology;Zhu;Nucl Med Mol Imaging.,2011

4. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages;Talks;Am J Pathol.,2000

5. Hypoxia-inducible factor 1a (HIF-1a) protein is rapidly degraded by the ubiquitin–proteasome system under normoxic conditions;Salceda;Am Soc Biochem Mol Biol.,1997

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine;European Journal of Nuclear Medicine and Molecular Imaging;2022-07-05

2. Intratumoral Injection of Anlotinib Hydrogel Combined With Radiotherapy Reduces Hypoxia in Lewis Lung Carcinoma Xenografts: Assessment by Micro Fluorine-18-fluoromisonidazole Positron Emission Tomography/Computed Tomography Hypoxia Imaging;Frontiers in Oncology;2021-03-12

3. Primary tumor standardized uptake value (SUVmax) measured on 18F-FDG PET/CT and mixed NSCLC components predict survival in surgical-resected combined small-cell lung cancer;Journal of Cancer Research and Clinical Oncology;2020-06-03